Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma

British Journal of Cancer - Tập 88 Số 1 - Trang 115-119 - 2003
Patricia Grabowski1, Thomas Kühnel1, Felix Mühr-Wilkenshoff1, Bernhard Heine2, Harald Stein2, Michael Höpfner1, Christoph T. Germer3, Hans Scherübl1
1Medical Clinic I, Gastroenterology/Infectious Diseases/Rheumatology, Benjamin Franklin Clinics, Berlin, Germany
2Institute of Pathology, Benjamin Franklin Clinics, Berlin, Germany
3Department of Surgery, Benjamin Franklin Clinics, Berlin, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Adida C, Berrebi D, Peuchmaur M, Reyes-Mugica M, Altieri DC (1998) Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 351: 882–883

Altieri DC, Marchisio PC, Marchisio C (1999) Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 79: 1327–1333

Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917–921

Deveraux QL, Reed JC (1999) IAP family proteins – suppressors of apoptosis. Genes Dev 13: 239–252

Endl E, Gerdes J (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257: 231–237

Gabbert HE, Shimoda T, Hainaut P, Nakamura Y, Field JK, Inoue H (2000) Squamous cell carcinoma of the ooesophagus. In Pathology and Genetics of Tumours of the Digestive System. World Health Organization Classification of Tumours, Hamilton SR, Aaltonen LA (eds) pp 11–19. Lyon: IARC Press.

Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, Shroyer KR (2001) Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 32: 119–125

Grabowski P, Schindler I, Anagnostopoulos I, Foss HD, Riecken EO, Mansmann U, Stein H, Berger G, Buhr HJ, Scherubl H (2001) Neuroendocrine differentiation is a relevant prognostic factor in stage III–IV colorectal cancer. Eur J Gastroenterol Hepatol 13: 405–411

Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, Nakano T, Suzuki A (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31: 1080–1085

Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, Fujii Y (2001) Expression of survivin in oesophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92–95

Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58: 5071–5074

Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580–584

Lo Muzio ML, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, Chieffi P, Tramontano D, De Rosa G, Altieri DC (2001) Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70: 249–254

Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17: 2100–2104

Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y (2001) Survivin expression in tumour cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163: 109–116

Rodriguez JA, Span SW, Ferreira CG, Kruyt FA, Giaccone G (2002) CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin. Exp Cell Res 275: 44–53

Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149–1163

Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315–5320

Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127–134

Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456–1462

Vaux DL, Korsmeyer SJ (1999) Cell death in development. Cell 96: 245–254

Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, Cook BP, Dufault MR, Ferguson AT, Gao Y, He TC, Hermeking H, Hiraldo SK, Hwang PM, Lopez MA, Luderer HF, Mathews B, Petroziello JM, Polyak K, Zawel L, Kinzler KW (1999) Analysis of human transcriptomes. Nat Genet 23: 387–388

Yang E, Korsmeyer SJ (1996) Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 88: 386–401